Literature DB >> 23474779

Assessment of disease behavior in patients with Crohn's disease by MR enterography.

Gabriela Schill1, Igors Iesalnieks, Michael Haimerl, René Müller-Wille, Lena-Marie Dendl, Philipp Wiggermann, Stephan Schleder, Janine Rennert, Claudia Ott, Ayman Agha, Christian Stroszczynski, Andreas G Schreyer.   

Abstract

BACKGROUND: Magnetic resonance imaging (MRI) of the bowel is an increasingly used modality to evaluate patients with Crohn's disease. The Montreal classification of the disease behavior is considered as an excellent prognostic and therapeutic parameter for these patients. In our study, we correlated the behavior assessment performed by a radiologist based on MRI with the surgeons' clinical assessment based on the assessment during abdominal surgery.
METHODS: We evaluated 76 patients with Crohn's disease, who underwent bowel resection and had an MRI within 4 weeks before surgery. Radiological behavior assessment was performed by 2 radiologists based on MRI. Behavior was classified into B1 (nonstricturing and nonpenetrating), B2, and B3 (penetrating) disease. Surgical assessment was done by the same surgeon, who performed all bowel resections, based on intraoperative findings and histologic results.
RESULTS: The surgical assessment identified 4 patients (5%) as B1, 16 patients (21%) as B2, and 56 patients (74%) as B3. In 97% (n = 74) of all patients, the intraoperative and radiological assessment were identical with interobserver agreement of 0.937. In one case, B2 was radiological considered as B1, and in another case, B3 was diagnosed as B2. The diagnosis of a stricture had the highest sensitivity of 96%, whereas the detection of inflammatory mass showed the lowest sensitivity of 81%. Abscesses had the lowest positive predictive value of 68% with a specificity of 88%. Best correlation was found for fistulae (0.895).
CONCLUSIONS: MRI represents an excellent imaging modality to correctly assess the Montreal classification-based disease behavior in patients scheduled for bowel resection with Crohn's disease.

Entities:  

Mesh:

Year:  2013        PMID: 23474779     DOI: 10.1097/MIB.0b013e31828029dd

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  5 in total

1.  Assessment of Imaging Features of Crohn's Disease with MR Enterography.

Authors:  Mehmet Onay; Ayşe Erden; Ali Burak Binboğa; Çetin Murat Altay; Murat Törüner
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

2.  Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodies.

Authors:  Piotr Eder; Michal Michalak; Katarzyna Katulska; Liliana Lykowska-Szuber; Iwona Krela-Kazmierczak; Kamila Stawczyk-Eder; Katarzyna Klimczak; Aleksandra Szymczak; Krzysztof Linke
Journal:  Sci Rep       Date:  2015-05-20       Impact factor: 4.379

3.  The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.

Authors:  Piotr Eder; Katarzyna Katulska; Iwona Krela-Kaźmierczak; Kamila Stawczyk-Eder; Katarzyna Klimczak; Aleksandra Szymczak; Krzysztof Linke; Liliana Łykowska-Szuber
Journal:  Abdom Imaging       Date:  2015-10

Review 4.  Grading of Crohn's disease activity using CT, MRI, US and scintigraphy: a meta-analysis.

Authors:  C A J Puylaert; J A W Tielbeek; S Bipat; J Stoker
Journal:  Eur Radiol       Date:  2015-06-17       Impact factor: 5.315

Review 5.  MRI for Crohn's Disease: Present and Future.

Authors:  Kichul Yoon; Kyu-Tae Chang; Hong J Lee
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.